Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer
Clinical trial NCT03647592 · UNKNOWN
Trial details
- NCT number
- NCT03647592
- Sponsor
- Hunan Province Tumor Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-06-01
- Primary completion
- 2024-08-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.